These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17365287)

  • 1. 1-O-alkylglycerol stabilized carbamazepine intravenous o/w nanoemulsions for drug targeting in mice.
    Madhusudhan B; Rambhau D; Apte SS; Gopinath D
    J Drug Target; 2007 Feb; 15(2):154-61. PubMed ID: 17365287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process.
    Kelmann RG; Kuminek G; Teixeira HF; Koester LS
    Int J Pharm; 2007 Sep; 342(1-2):231-9. PubMed ID: 17582711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa.
    Samia O; Hanan R; Kamal el T
    Drug Deliv; 2012 Jan; 19(1):58-67. PubMed ID: 22191715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoemulsion-based Parenteral Drug Delivery System of Carbamazepine: Preparation, Characterization, Stability Evaluation and Blood-Brain Pharmacokinetics.
    Tan SL; Stanslas J; Basri M; Abedi Karjiban RA; Kirby BP; Sani D; Basri HB
    Curr Drug Deliv; 2015; 12(6):795-804. PubMed ID: 26324229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus.
    Löscher W; Hönack D
    Epilepsia; 1997 Jan; 38(1):106-13. PubMed ID: 9024191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions.
    Brewster ME; Anderson WR; Meinsma D; Moreno D; Webb AI; Pablo L; Estes KS; Derendorf H; Bodor N; Sawchuk R; Cheung B; Pop E
    J Pharm Sci; 1997 Mar; 86(3):335-9. PubMed ID: 9050802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study on the development of nanoemulsions for carbamazepine intravenous delivery: an investigation of drug polymorphic transition.
    Kelmann RG; Kuminek G; Teixeira HF; Koester LS
    Drug Dev Ind Pharm; 2008 Jan; 34(1):53-8. PubMed ID: 18214755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus.
    Patel V; Cordato DJ; Malkan A; Beran RG
    Epilepsy Behav; 2014 Feb; 31():31-3. PubMed ID: 24333499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study.
    Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
    Drug Deliv; 2016; 23(1):207-13. PubMed ID: 24825492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous carbamazepine: a new formulation of a familiar drug.
    Klein P; Tolbert D
    Expert Rev Neurother; 2017 Sep; 17(9):851-860. PubMed ID: 28783998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles.
    Ana R; Mendes M; Sousa J; Pais A; Falcão A; Fortuna A; Vitorino C
    Int J Pharm; 2019 Jan; 554():352-365. PubMed ID: 30439493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of carbamazepine pharmacokinetic profiles in mice with kainic acid-induced acute seizures.
    Nishimura A; Honda N; Sugioka N; Takada K; Shibata N
    Biol Pharm Bull; 2008 Dec; 31(12):2302-8. PubMed ID: 19043217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures.
    Franco V; Iudice A; Grillo E; Citraro R; De Sarro G; Russo E
    Expert Opin Pharmacother; 2014 Apr; 15(5):637-44. PubMed ID: 24437529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
    Miller AD; Krauss GL; Hamzeh FM
    Acta Neurol Scand; 2004 Jun; 109(6):374-7. PubMed ID: 15147458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Carbamazepine for Adults With Seizures.
    Vickery PB; Tillery EE; DeFalco AP
    Ann Pharmacother; 2018 Mar; 52(3):285-289. PubMed ID: 29020805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous carbamazepine for the treatment of epilepsy.
    Brigo F; Leo A; Russo E; Striano P; Belcastro V
    Expert Opin Pharmacother; 2018 May; 19(7):743-747. PubMed ID: 29648925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single and multiple dose bioavailability study with carbamazepine 400 mg retard tablets with reference to enzyme autoinduction and circadian time differences.
    Hoffmann C; Zschiesche M; Franke G; Hoffmann A; Terhaag B; Möritz KU; Siegmund W
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):496-503. PubMed ID: 9401830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
    Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
    Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
    Löscher W; Hönack D; Richter A; Schulz HU; Schürer M; Düsing R; Brewster ME
    Epilepsia; 1995 Mar; 36(3):255-61. PubMed ID: 7614909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.